Fundraising Fox
🦊/Companies
Sign in

Imaginostics

Orlando, US · Delaware corporation · 2 known investors

Find your way into Imaginostics

393 people in our graph share verified history with the Imaginostics team — schools, employers, funds. One of them is your warm intro.

Ben Robbinsunlockedknows Codi Gharagouzloo · together at Harvard Medical School (overlapped)
×4knows the team · via Northeastern University
×2knows the team · via Harvard Medical School
×4knows the team · via Universidad Complutense de Madrid
knows the team · via Ecole normale supérieure
Biotech

Founders & leadership

CGCodi Gharagouzloo
Codi GharagouzlooinFounder · President & CSOCodi Gharagouzloo holds a Ph.D. in Bioengineering from Northeastern University and completed a postdoctoral fellowship at Massachusetts General Hospital and Harvard Medical School, with expertise in MRI physics and contrast-enhanced imaging. He founded Imaginostics in 2018 to develop vascular imaging biomarkers and the QUTE-CE MRI technology for medical diagnostics.
SH
Scott HogeExecutive
VA
Valerie Aimee GharagouzlooNamed on SEC filing

Investors · 2

Ideashipreported · 2 sourcesPortland

Also in the syndicate · 1

Alzheimer’s Drug Discovery Foundation (ADDF)

Reported raises · per SEC filings

Form D private placements

$7.2M disclosed across 7 rounds · 2018–2026

▶$40KraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CODI GHARAGOUZLOOExecutive Officer, Director, Promoter
  • VALERIE AIMEE GHARAGOUZLOOExecutive Officer, Director, Promoter
  • WILLIAM SCOTT HOGEExecutive Officer
Amount sold
$40K
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50KraisedApr 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott HogeExecutive Officer
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
  • Codi GharagouzlooExecutive Officer, Director, Promoter
Amount sold
$50K
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedApr 2026 · 75 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott ScHogeExecutive Officer
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
  • Codi GharagouzlooExecutive Officer, Director, Promoter
Amount sold
$5.4M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$725.3KraisedApr 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
  • Codi GharagouzlooExecutive Officer, Director, Promoter
  • Scott HogeExecutive Officer
Offering amount
$725.3K
Amount sold
$725.3K
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedApr 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Codi GharagouzlooExecutive Officer, Director, Promoter
  • Scott HogeExecutive Officer
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
Amount sold
$400K
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$516.9KraisedApr 2026 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
  • Codi GharagouzlooExecutive Officer, Director, Promoter
  • Scott HogeExecutive Officer
Amount sold
$516.9K
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedApr 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott HogeExecutive Officer
  • Codi GharagouzlooExecutive Officer, Director, Promoter
  • Valerie Aimee GharagouzlooExecutive Officer, Director, Promoter
Amount sold
$100K
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Imagen8 shared keywordsImagen builds diagnostic imaging technology that combines clinical expertise and advanced technology to deliver consistent high-quality diagnostic care across healthcare sites. The company serves healthcare organizations, radiologists, and physician groups seeking to improve diagnostic imaging performance and patient outcomes.

Companies competing with Imaginostics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$915.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$436.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Imaginostics has filed a notice of an exempt offering of securities to raise $7,595,768.00 in New Funding. - intelligence360intelligence360.news · Apr 2026The Remarkable Journey of Imaginostics: Imaging Diagnostics Beyond Geographic and Scientific Frontiers — StartUp Healthstartuphealth.com · Apr 2025Imaginostics Receives $725k Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) for Clinical Validation of its Biomarkers in Alzheimer’s Disease and Related Dementias - Imaginosticsimaginostics.com · Sep 2022Ideaship Invests in Imaginostics | GTT Group | Portland, Oregongttgrp.com · Jan 2021

Frequently asked questions

Who founded Imaginostics?
Imaginostics was founded by Codi Gharagouzloo.
Who are Imaginostics's investors?
Imaginostics's investors include Ideaship.
How much funding has Imaginostics raised?
Imaginostics has disclosed $7.2M raised across 7 rounds.
Where is Imaginostics headquartered?
Imaginostics is headquartered in Orlando, US.